| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.014 | 1 |